Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Lantern Pharma Inc. (LTRN) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.33M |
|
-- |
|
-- |
|
$3.41M |
|
$-3.41M |
|
$0.08M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.33M |
|
$-3.41M |
|
$-3.40M |
|
11.25M |
|
11.25M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$7.06M |
|
$0.03M |
|
$0.17M |
|
$7.22M |
|
$3.78M |
|
-- |
|
-- |
|
$3.78M |
|
$3.45M |
|
$3.45M |
|
$3.45M |
|
11.26M |
|
| Cash Flow Statement Financials | |
$-3.77M |
|
$4.25M |
|
-- |
|
$4.42M |
|
$4.92M |
|
$0.49M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.87 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-96.62% |
|
-96.62% |
|
-46.09% |
|
-96.62% |
|
$0.31 |
|
$-0.34 |
|
$-0.34 |
|